Neuralstem (NYSE:CUR)‘s stock had its “buy” rating reissued by research analysts at Brean Capital in a note issued to investors on Thursday, Analyst Ratings.Net reports. Separately, MLV & Co. assumed …
Ticker Report · 10/1/2015
Akebia's stock price rose following the release of the new phase II ... asks, "Has your negative opinion of Neuralstem (CUR - Get Report) changed now that updated results from its ALS treatment have been announced?
The Street · ByAdam Feuerstein · 10/2/2015
Neuralstem, Inc. (Nasdaq: CUR), a biopharmaceutical company using neural stem cell technology to develop small molecule and cell therapy treatments for central nervous system diseases, announced that principal investigator, Eva Feldman, MD, PhD ...
StreetInsider · 9/24/2015
cell therapy
Neuralstem (NYSE:CUR) – Johe Karl sold 25,000 stocks at $1.64 ... NOTE: Information with regards the stock market’s insider trading as shown on this page have been generated on share prices 30 minutes prior to …
Fx Pips · 9/30/2015
The stock should run into initial resistance at its 50-day moving ... Unilever (NYSE:UN) is one of today's biggest movers, up 3.6% to $39.80. The S&P is cur ... One of today's stocks on the move is Gulfmark Offshore (NYSE:GLF), down 3.6% to $6.66.
Financial News Network Online · ByMallory Stone · 9/25/2015
He worked at Fox Rothschild during the firm's handling of the merger and allegedly bought and sold Harleysville stock knowing that the merger was imminent, making profits of $75,500, according to the grand jury … · 1 day ago
Your article was successfully shared with the contacts you provided. A former petroleum executive's decision to drag his feet in transferring company stock to his ex-wife will cost him $34.6 million. A Sarasota judge …
Daily Business Review · 10/4/2015
Todd Kozel
Affirming the conviction of stock manipulator David Levy, the circuit said that border officers can act on the reasonable suspicion of another federal agency when they go beyond inspection of a document, copying it for …
New York Law Journal · 1 day ago
Border Search
I have been a buyer of CUR this year, and have added to my position as the stock moved higher. My first buy was when I wrote my first article here at a price of $1.20, and since then the price has doubled. The trend remains up, and we don't fight the trend.
Seeking Alpha · 12/9/2013
Among the hedge funds that we track, three investment managers have stock positions in Neuralstem, Inc. (NYSEMKT:CUR) indicating confidence in the company. Ken Griffin’s Citadel Investment Group is by far the largest stockholder of the company and …
INSIDER MONKEY · 6/26/2015